scholarly journals Stem cell therapy in animal models of central nervous system (CNS) diseases: therapeutic role, challenges and perspectives

2014 ◽  
Vol 1 (3) ◽  
pp. 75
Author(s):  
Swapan Maiti ◽  
AR Ninu ◽  
V Remya ◽  
TB Sivanarayanan ◽  
Susan Cherian ◽  
...  
2014 ◽  
Vol 2014 ◽  
pp. 1-12 ◽  
Author(s):  
Gregory E. Tullis ◽  
Kathleen Spears ◽  
Mark D. Kirk

The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer’s disease that result in the extensive loss of neuronal cells. Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders. Although stem cell therapy has shown some promising results in animal models for many brain disorders it has yet to translate into the clinic. A major hurdle to the translation of stem cell therapy into the clinic is the immune response faced by stem cell transplants. Here, we focus on immunological and related hurdles to stem cell therapies for central nervous system disorders.


2015 ◽  
Vol 1 (2) ◽  
pp. 125 ◽  
Author(s):  
CesarioV Borlongan ◽  
Paola Suárez-Meade ◽  
HoracioG Carvajal ◽  
Takao Yasuhara ◽  
Naoki Tajiri ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Yu-Ting Zhang ◽  
Kai-Jie He ◽  
Jin-Bao Zhang ◽  
Quan-Hong Ma ◽  
Fen Wang ◽  
...  

AbstractStem cells are characterized by their self-renewal and multipotency and have great potential in the therapy of various disorders. However, the blood–brain barrier (BBB) limits the application of stem cells in the therapy of neurological disorders, especially in a noninvasive way. It has been shown that small molecular substances, macromolecular proteins, and even stem cells can bypass the BBB and reach the brain parenchyma following intranasal administration. Here, we review the possible brain-entry routes of transnasal treatment, the cell types, and diseases involved in intranasal stem cell therapy, and discuss its advantages and disadvantages in the treatment of central nervous system diseases, to provide a reference for the application of intranasal stem cell therapy.


RSC Advances ◽  
2017 ◽  
Vol 7 (30) ◽  
pp. 18668-18680 ◽  
Author(s):  
Hugh H. Chan ◽  
Connor A. Wathen ◽  
Ming Ni ◽  
Shuangmu Zhuo

We report the facilitation of stem cell therapy in stroke by tissue engineering and applications of biomaterials.


PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0149400 ◽  
Author(s):  
Feng Li ◽  
Changlin Zhou ◽  
Liang Xu ◽  
Shuqing Tao ◽  
Jingyi Zhao ◽  
...  

2017 ◽  
Vol 228 ◽  
pp. 465-480 ◽  
Author(s):  
Fábio Trindade ◽  
Adelino Leite-Moreira ◽  
João Ferreira-Martins ◽  
Rita Ferreira ◽  
Inês Falcão-Pires ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document